The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT05464095

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05464095
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05464095. Randomized; double masking; primary purpose treatment. Start 2023-01-01 (actual); primary completion 2027-05-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
Acronym
MOVE PAH)
Condition
Pulmonary Arterial Hypertension
Intervention (Device)
mHealth Intervention
Intervention (Device)
Usual Care
Lead sponsor
Vanderbilt University Medical Center (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05464095
Content hash
9f5c7852b7824717dd5fae78580e3df3b1002732fdb5d97ccd646ba7f475fd7d